Splicing mosaic of the myophosphorylase gene due to a silent mutation in McArdle disease
- 25 November 2003
- journal article
- Published by Wolters Kluwer Health in Neurology
- Vol. 61 (10), 1432-1434
- https://doi.org/10.1212/wnl.61.10.1432
Abstract
The authors report the molecular findings in a patient with McArdle disease who harbored a silent polymorphism (K608K) in the myophosphorylase gene. cDNA studies demonstrated that this polymorphism leads to a severe mosaic alteration in mRNA splicing, including exon skipping, activation of cryptic splice-sites, and exon-intron reorganizations. These findings suggest that, in patients with McArdle disease in whom no pathogenic mutation has been found, any a priori silent polymorphism should be re-evaluated as a putative splicing mutation.Keywords
This publication has 8 references indexed in Scilit:
- Two novel mutations in the muscle glycogen phosphorylase gene in McArdle's diseaseMuscle & Nerve, 2003
- Listening to silence and understanding nonsense: exonic mutations that affect splicingNature Reviews Genetics, 2002
- Myophosphorylase Deficiency (Glycogenosis Type V McArdle Disease)Current Molecular Medicine, 2002
- Molecular heterogeneity of myophosphorylase deficiency (Mcardle's disease): A genotype‐phenotype correlation studyAnnals of Neurology, 2001
- The association of nonsense codons with exon skippingMutation Research, 1998
- Molecular genetic analysis of McArdle's disease in Spanish patientsNeurology, 1998
- Nearby Stop Codons in Exons of the Neurofibromatosis Type 1 Gene Are Disparate Splice EffectorsAmerican Journal of Human Genetics, 1998
- Manifesting heterozygotes in McArdle's disease: clinical, morphological and biochemical studies in a familyJournal of the Neurological Sciences, 1993